Position in BIOA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,736,099
+$1,065,971 QoQ
Shares Held
156,438
+23.9% QoQ
Ownership
0.352%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 99.24890371904524.ToString("F0")%
Shared 0.ToString("F0")%
None 0.7510962809547552.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $1,741,757,397 across 53 Drug Manufacturers - Specialty & Generic names. BIOA ranks #40 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,730,785 | $441,016,092 | |
| 2 | VTRS |
Viatris Inc
|
13,717,622 | $185,325,071 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,826,245 | $145,366,498 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
5,618,728 | $104,058,841 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,409,165 | $73,431,349 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
114,419 | $67,848,177 | |
| 7 | ALKS |
Alkermes plc.
|
1,882,178 | $66,553,812 | |
| 8 | HLN |
Haleon plc
|
6,127,452 | $61,335,793 |
All Filings in BIOA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,736,099 | 156,438 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,670,128 | 126,238 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $527,306 | 89,678 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $102,390 | 24,792 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $100,613 | 26,759 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,134,648 | 195,967 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,259,212 | 108,616 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||